Skip to main content

MAI Capital Management

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1040197 INDEPENDENCE, OH

Position in LCTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$25,088
-$2,669 QoQ
Shares Held
15,879
-4.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MAI Capital Management holds $16,740,876 across 273 Biotechnology names. LCTX ranks #53 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LCTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $25,088 15,879
2025-12-31 $27,757 16,621
2025-09-30 $31,124 18,417
2025-06-30 $17,339 19,054
2025-03-31 $28,975 64,391
2024-12-31 $328,839 657,679
2024-09-30 $1,523,957 1,674,679
2024-06-30 $1,638,772 1,638,772
2024-03-31 $2,206,475 1,490,862
2023-12-31 $876,191 803,845
2023-09-30 $1,126,531 954,688
2023-06-30 $1,341,724 951,578
2023-03-31 $637,672 425,115
2022-12-31 $534,475 456,817
2022-09-30 $589,713 521,870
2022-06-30 $391,421 247,735